Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors
(se abrirá en una nueva ventana)
Autores:
Antje Neeb, Nicolás Herranz, Sara Arce-Gallego, Susana Miranda, Lorenzo Buroni, Wei Yuan, Alejandro Athie, Teresa Casals, Juliet Carmichael, Daniel Nava Rodrigues, Bora Gurel, Pasquale Rescigno, Jan Rekowski, Jon Welti, Ruth Riisnaes, Veronica Gil, Jian Ning, Verena Wagner, Irene Casanova-Salas, Sarai Cordoba, Natalia Castro, Maria Dolores Fenor de la Maza, George Seed, Khobe Chandran, Ana Ferrei
Publicado en:
European Urology, Edición 79/2, 2021, Página(s) 200-211, ISSN 0302-2838
Editor:
Elsevier BV
DOI:
10.1016/j.eururo.2020.10.029
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
(se abrirá en una nueva ventana)
Autores:
Suzanne Carreira, Nuria Porta, Sara Arce-Gallego, George Seed, Alba Llop-Guevara, Diletta Bianchini, Pasquale Rescigno, Alec Paschalis, Claudia Bertan, Chloe Baker, Jane Goodall, Susana Miranda, Ruth Riisnaes, Ines Figueiredo, Ana Ferreira, Rita Pereira, Mateus Crespo, Bora Gurel, Daniel Nava Rodrigues, Stephen J Pettitt, Wei Yuan, Violeta Serra, Jan Rekowski, Christopher J Lord, Emma Hall, Joaqui
Publicado en:
Cancer Discovery, 2021, Página(s) candisc.0007.2021, ISSN 2159-8274
Editor:
American Association for Cancer Research Inc.
DOI:
10.1158/2159-8290.cd-21-0007